Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada.
BMJ Open. 2023 Jun 9;13(6):e073782. doi: 10.1136/bmjopen-2023-073782.
Among people with immune-mediated inflammatory disease (IMID), including multiple sclerosis (MS), inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) most research has focused on mental illness rather than on mental health. We assessed dimensions of mental health among persons with IMID and compared them across IMID. We also evaluated demographic and clinical characteristics associated with flourishing mental health.
Participants: Adults with an IMID (MS, 239; IBD, 225; RA 134; total 598) who were participating in a cohort study.
Tertiary care centre in Manitoba, Canada.
Participants completed the Mental Health Continuum Short-Form (MHC-SF), which measures emotional, psychological and social well-being, and identifies flourishing mental health. This outcome was added midway through the study on the advice of the patient advisory group. Depression, anxiety, pain, fatigue and physical function were also assessed.
Total MHC-SF and subscale scores were similar across IMID groups. Nearly 60% of participants were considered to have flourishing mental health, with similar proportions across disease types (MS 56.5%; IBD 58.7%; RA 59%, p=0.95). Older age was associated with a 2% increased odds of flourishing mental health per year of age (OR 1.02; 95% CI: 1.01 to 1.04). Clinically meaningful elevations in anxiety (OR 0.25; 95% CI: 0.12 to 0.51) and depressive symptoms (OR 0.074; 95% CI: 0.009 to 0.61) were associated with lower odds. Higher levels of pain, anxiety and depressive symptoms were associated with lower total Mental Health Continuum scores at the 50th quantile.
Over half of people with MS, IBD and RA reported flourishing mental health, with levels similar across the disease groups. Interventions targeting symptoms of depression and anxiety, and upper limb impairments, as well as resilience training may help a higher proportion of the IMID population achieve flourishing mental health.
在患有免疫介导的炎症性疾病(IMID)的人群中,包括多发性硬化症(MS)、炎症性肠病(IBD)和类风湿关节炎(RA),大多数研究都集中在精神疾病上,而不是精神健康上。我们评估了 IMID 患者的精神健康状况,并对其进行了比较。我们还评估了与心理健康良好相关的人口统计学和临床特征。
参与者:参加队列研究的成年人 IMID(MS,239 例;IBD,225 例;RA,134 例;总计 598 例)。
加拿大马尼托巴省的一个三级保健中心。
参与者完成了心理健康连续体简明量表(MHC-SF),该量表衡量情感、心理和社会福祉,并确定心理健康良好。这一结果是在患者咨询小组的建议下,在研究进行到一半时增加的。还评估了抑郁、焦虑、疼痛、疲劳和身体功能。
MHC-SF 总分和子量表评分在 IMID 组之间相似。近 60%的参与者被认为具有心理健康良好,不同疾病类型的比例相似(MS,56.5%;IBD,58.7%;RA,59%,p=0.95)。年龄每增加 1 岁,心理健康良好的可能性就会增加 2%(OR 1.02;95%CI:1.01 至 1.04)。焦虑症(OR 0.25;95%CI:0.12 至 0.51)和抑郁症状(OR 0.074;95%CI:0.009 至 0.61)的临床显著升高与较低的可能性相关。疼痛、焦虑和抑郁症状水平较高与第 50 个百分位数的总心理健康连续体评分较低相关。
超过一半的多发性硬化症、炎症性肠病和类风湿关节炎患者报告了心理健康良好,且在疾病组之间水平相似。针对抑郁和焦虑症状以及上肢功能障碍的干预措施,以及韧性训练,可能有助于提高 IMID 人群中心理健康良好的比例。